Linzess linaclotide 0.145 MG Oral Capsule Linzess

1 INDICATIONS AND USAGE LINZESS is indicated for the treatment of: • irritable bowel syndrome with constipation (IBS-C) in adults • chronic idiopathic constipation (CIC) in adults • functional constipation (FC) in pediatric patients 6 to 17 years of age LINZESS is a guanylate cyclase-C agonist indicated for treatment of: Irritable bowel syndrome with constipation (IBS-C) in adults. ( 1 ) Chronic idiopathic constipation (CIC) in adults. ( 1 ) Functional constipation (FC) in pediatric patients 6 to 17 years of age. ( 1 )

Forest Laboratories, Inc.

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] off label use` `[4] nausea` `[5] diarrhoea` `[6] pain` `[7] headache` `[8] dyspnoea` `[9] vomiting` `[10] arthralgia`

7 years ago

CAPSULE WHITE FL 145

16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied LINZESS capsule Strength Description Packaging NDC number 72 mcg white to off-white opaque hard gelatin capsules with gray imprint “FL 72” Bottle of 30 0456-1203-30 145 mcg white to off-white opaque hard gelatin capsules with gray imprint "FL 145" Bottle of 30 0456-1201-30 290 mcg white to off-white opaque hard gelatin capsules with gray imprint "FL 290" Bottle of 30 0456-1202-30 Storage Store at 25°C (77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Keep LINZESS in the original container. Do not subdivide or repackage. Protect from moisture. Do not remove desiccant from the container. Keep bottles tightly closed in a dry place.

More pills like CAPSULE FL 145

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site

Linzess linaclotide 0.145 MG Oral Capsule Linzess

FDA Reported Adverse Reactions [1] drug ineffective [2] fatigue [3] off label use [4] nausea [5] diarrhoea [6] pain [7] headache [8] dyspnoea [9] vomiting [10] arthralgia

CAPSULE WHITE FL 145

More pills like CAPSULE FL 145

FDA Reported Adverse Reactions
`[1] drug ineffective` `[2] fatigue` `[3] off label use` `[4] nausea` `[5] diarrhoea` `[6] pain` `[7] headache` `[8] dyspnoea` `[9] vomiting` `[10] arthralgia`